CN1383729A - Polypeptide fortified milk - Google Patents
Polypeptide fortified milk Download PDFInfo
- Publication number
- CN1383729A CN1383729A CN 01115241 CN01115241A CN1383729A CN 1383729 A CN1383729 A CN 1383729A CN 01115241 CN01115241 CN 01115241 CN 01115241 A CN01115241 A CN 01115241A CN 1383729 A CN1383729 A CN 1383729A
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- milk
- peptide
- casein
- accounts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Polypeptide fortified milk is produced by adding composite casein polypeptide into fresh milk before common subsequent milk processing steps. It has the bioactive effect of composite casein polypeptide other than the nutritious and health functions similar to those of common milk.
Description
The present invention relates to a kind of fortified milk that contains the casein polypeptide.
Milk is popular a kind of nutraceutical of generally acknowledging.Its composition proportion is reasonable, and it is rich in protein, minerals and vitamins, is suitable to people of all ages food.But it also is short of aspect physiological function to some extent, because protein must just absorb by after digesting in vivo, and the end product that protein is digested in vivo all is an amino acid, and the peptide section is seldom arranged, and this has just weakened its bioavailability.
Polypeptide is a kind of bioactivator, can directly be absorbed by human body, and different peptides has different physiological functions.The peptide that studies have shown that in the cow's milk peptide has: the blood pressure lowering peptide that suppresses angiotensin I invertase activity; The morphine-like peptide that tranquilizing soporific is arranged; The immunomodulatory peptides that can suppress bacterium and virus infections; Antiplatelet cohesion and fibrinogen are attached to the antithrombotic peptide on the blood platelet that ADP activates; Promote the CPP that calcium, iron, zinc absorb; Promote the peptide that DNA is synthetic and cell is grown; Antibiotic anticancer anti-mutagenized polypeptide etc.
At present, external active casein polypeptide played a part with different effects in fields such as health products, medicine, beverage additive, family's non-staple food special.Casein is degraded to the focus that active peptides is present dairy products research and development with various enzymes.Abroad, the part casein peptide is commercialization and very fast-selling, aspect this biotechnology, at present Japan and Northern Europe are walked in prostatitis, secondly countries such as the U.S., Australia, Germany, France, Korea S all carry out positive research, and in the end of the year 1989, Japan has at first realized CPP suitability for industrialized production, release the functional food that contains active peptides simultaneously, Denmark also realized commercialization in 1991.Functional food comes from Japan, and is also in vogue in Japan at present.Japan has been applied to polypeptide the beverage that children's curry meal, liquid nutritional food, candy, strong bone are replenished the calcium, allergic reaction dairy produce for baby " MA-1 ", " MA-2 " etc.Taiwan also has the CPP beverage that all contains of commodity " the good iron of calcium " by name to go on the market, and the utmost point gets consumer reception.France successfully is that the antithrombotic peptide of raw material behind enzymolysis made the product that prevents and treat thrombotic disease with CMP in the nineties.
The chemical elementary cell of active casein polypeptide is an amino acid, constitutes the different peptides with given efficacy because of amino acid whose composition is different.Product appearance is white or light yellow powdery, has unique bitter taste when debitterize is not distinguished the flavor of, and is soluble in water, because its very high nutritive value and specific physiological function are widely used in fields such as grocery trade, health products, medicine, feed, family's non-staple food.
The objective of the invention is composite casein polypeptide to be added in the milk in order to provide a kind of, utilize the biologically active of polypeptide to replenish the biologically active that is lacked in the milk, make it become the polypeptide fortified milk that not only has the nutrition health-care functions of milk but also have the biological action of composite casein polypeptide.
Purpose of the present invention can realize by following measure:
A kind of polypeptide fortified milk is to finish subsequent handling by known operation after the adding composite casein polypeptide mixes before fresh milk is not sterilized to get final product, and wherein composite casein polypeptide accounts for the 0.5-2% of milk wt.
The present invention has following advantage compared to existing technology:
1, the present invention adds the composite casein polypeptide of tool bioactivator in the milk to, utilizes the biologically active of polypeptide to replenish the biologically active that is lacked in the milk; Make it both have a trophism of milk, have the biological action of composite casein polypeptide again,, simultaneously some disease is also had special dietary function, make it meet the theory of the integration of drinking and medicinal herbs on the theory of traditional Chinese medical science for a kind of multi-functional nutritional health food.
2, the present invention can play human body and regulate immunity of organisms, delay senility, anti-mutagenesis, prevent effect such as osteoporosis.
The present invention also will be described in further detail in conjunction with the embodiments:
Embodiment one:
A kind of polypeptide fortified milk is to add casein phosphopeptide, calcium peptide in the fresh milk of not sterilization, and wherein casein phosphopeptide accounts for 0.3% of milk wt, and CCP accounts for 0.2% of milk wt; Promptly can be made into polypeptide fortified milk with finishing subsequent handling by known operation behind casein phosphopeptide, calcium peptide and the milk mixing.
Embodiment two:
A kind of polypeptide fortified milk is to add casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide in the fresh milk of not sterilization, wherein casein phosphopeptide accounts for 0.1% of milk wt, CCP accounts for 0.1% of milk wt, blood pressure lowering peptide accounts for 1% of milk wt, and the antithrombotic peptide accounts for 0.1% of milk wt; Promptly can be made into polypeptide fortified milk with finishing subsequent handling by known operation behind casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide and the milk mixing.
Embodiment three:
A kind of polypeptide fortified milk is to add casein phosphopeptide, calcium peptide blood pressure lowering peptide, antithrombotic peptide, morphine peptide, immunomodulatory peptides, anti-mutagenized polypeptide in the fresh milk of not sterilization, wherein casein phosphopeptide accounts for 0.5% of milk wt, CCP accounts for 0.2% of milk wt, blood pressure lowering peptide accounts for 0.1% of milk wt, the antithrombotic peptide accounts for 0.2% of milk wt, the morphine peptide accounts for 0.5% of milk wt, and immunomodulatory peptides accounts for 0.4% of milk wt, and anti-mutagenized polypeptide accounts for 0.1% of milk wt; Promptly can be made into polypeptide fortified milk with finishing subsequent handling by known operation behind casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide, morphine peptide, immunomodulatory peptides, anti-mutagenized polypeptide and the milk mixing.
Claims (2)
1, a kind of polypeptide fortified milk is characterized in that finishing subsequent handling by known operation after the adding composite casein polypeptide mixes before fresh milk is not sterilized gets final product, and wherein composite casein polypeptide accounts for the 0.5-2% of milk wt.
2, polypeptide fortified milk as claimed in claim 1 is characterized in that at least two kinds of peptides that described composite casein polypeptide is selected from casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide, morphine peptide, immunomodulatory peptides, the anti-mutagenized polypeptide mix the formation complex polypeptide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01115241 CN1199573C (en) | 2001-04-27 | 2001-04-27 | Polypeptide fortified milk |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01115241 CN1199573C (en) | 2001-04-27 | 2001-04-27 | Polypeptide fortified milk |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1383729A true CN1383729A (en) | 2002-12-11 |
CN1199573C CN1199573C (en) | 2005-05-04 |
Family
ID=4661818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 01115241 Expired - Fee Related CN1199573C (en) | 2001-04-27 | 2001-04-27 | Polypeptide fortified milk |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1199573C (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1316907C (en) * | 2005-06-14 | 2007-05-23 | 张剑平 | Polypeptide almond milk and preparation method thereof |
CN101422195B (en) * | 2008-10-28 | 2011-10-26 | 山东好当家海洋发展股份有限公司 | Jellyfish active peptide yoghourt and preparation method thereof |
-
2001
- 2001-04-27 CN CN 01115241 patent/CN1199573C/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1316907C (en) * | 2005-06-14 | 2007-05-23 | 张剑平 | Polypeptide almond milk and preparation method thereof |
CN101422195B (en) * | 2008-10-28 | 2011-10-26 | 山东好当家海洋发展股份有限公司 | Jellyfish active peptide yoghourt and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1199573C (en) | 2005-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1275534C (en) | Corn peptide beverage and its processing method | |
CN100423655C (en) | Rose beverage | |
CN101518295B (en) | Method for preparing powder rich in whey small peptides with molecular weight of 1000 daltons | |
WO2011160420A1 (en) | Green milk | |
CN102125101B (en) | Environmental-friendly heath-preserving milk and preparation method thereof | |
CN102228303A (en) | Solid preparation of fruit vinegar effervescent tablets and processing technology thereof | |
CN101214051A (en) | Donkey-hide gelatin jujube beverage and preparation thereof | |
CN102986883A (en) | Rose milk tea and making method thereof | |
CN1141394C (en) | Production process of active casein polypeptide with coarse cheese | |
CN104507334B (en) | New protein material | |
CN104397292A (en) | Folium mori granulated tea and preparation method thereof | |
CN1199573C (en) | Polypeptide fortified milk | |
CN1173648C (en) | Composite casein polypeptide beverage | |
CN1173633C (en) | Polypeptide biscuit | |
CN108813632A (en) | A kind of alimentation composition and its application containing lactoferrin | |
CN1173632C (en) | Nutritious health polypeptide flour | |
CN101283705A (en) | Milk powder containing peptide constituents and its preparation method | |
CN101983721B (en) | Desert cistanche calcium composition having functions of fatigue resistance and calcium supplement | |
CN1164191C (en) | Polypeptide chewing gum | |
CN1489934A (en) | Soya bean beverage | |
CN1383737A (en) | Polypeptide bean curd | |
CN103120212A (en) | Fortified milk | |
CN1383745A (en) | Casein and composite polypeptide casein | |
CN101868475A (en) | Food material for inhibiting bone resorption | |
CN109418403A (en) | A kind of fortified milk |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050504 Termination date: 20100427 |